
Article 1 
Foods and food ingredients produced from genetically modified maize line GA21 (hereinafter referred to as the products), as designated and specified in the Annex, may be placed on the Community market as novel foods or novel food ingredients.
Article 2 
The products shall be labelled as ‘genetically modified maize’ or ‘produced from genetically modified maize’ in accordance with the labelling requirements laid down in Article 13 of Regulation (EC) No 1829/2003.
Article 3 
The products and the information included in the Annex shall be entered in the Community Register of genetically modified food and feed.
Article 4 
This Decision is addressed to Monsanto Europe SA, Belgium, representing Monsanto Company, USA. It shall be valid for a period of 10 years.
Done at Brussels, 13 January 2006.
For the Commission
Markos KYPRIANOU
Member of the Commission
ANNEX

1. Applicant and authorisation holderNameMonsanto Europe SA.AddressAvenue de Tervuren 270-272, B-1150 Brussels, Belgium.On behalf of Monsanto Company, 800 N. Lindbergh Boulevard, St Louis, Missouri 63167, USA.2. Designation and specification of the productsFoods and food ingredients produced from genetically modified maize (Zea mays L.) line GA21 with increased tolerance to the herbicide glyphosate and from all its crosses with traditionally bred maize lines. GA21 maize contains the modified 5-enolpyruvylshikimate-3-phosphate synthase (mEPSPS) coding sequence under the regulation of the rice actin 1 promoter (r-act) and an optimised transit peptide (OPT) sequence based on chloroplast transit peptide sequences from Helianthus annuus and the RuBisCo gene from Zea mays L.3. Labelling‘Genetically modified maize’ or ‘produced from genetically modified maize’.4. Method for detection
— Event specific real-time quantitative PCR based method for genetically modified maize line GA21,
— Validated by the Joint Research Centre (JRC) of the European Commission, in collaboration with the European Network of GMO Laboratories (ENGL), published at http://gmo-crl.jrc.it/statusofdoss.htm
— Reference Material: IRMM-414 produced by the Joint Research Centre (JRC) of the European Commission.5. Unique identifierMON-ØØØ21-9.6. Information required under Annex II to the Cartagena ProtocolNot applicable.7. Conditions or restrictions for the placing on the market of the productNot applicable.8. Post market monitoring requirementsNot applicable.
